Secure Drug Supply Chain Act of 2026

II

119TH CONGRESS

2D SESSION

S. 5043

To direct the Food and Drug Administration to prevent the importation

of counterfeit, unapproved, misbranded, or adulterated drugs from the

People’s Republic of China or other foreign countries, to establish en-

hanced safeguards for imported drug products, and for other purposes.